Ignite Creation Date:
2024-10-26 @ 3:40 PM
Last Modification Date:
2024-10-26 @ 3:40 PM
Study NCT ID:
NCT06605911
Status:
COMPLETED
Last Update Posted:
None
First Post:
2024-09-10
Brief Title:
Assessment of the Efficacy of Topical Curcumin in Treatment of Oral Lichen Planus
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Assessment of the Efficacy of Topical Applied Curcumin 1 as Alternative or Complementary to Triamcinolone Acetonate in Treatment of Oral Lichen PlanusRandomise Control Trial
Status:
COMPLETED
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
to evaluate the therapeutic impact of curcumin as Alternative or Complementary to Triamcinolone Acetonate in Treatment of Oral Lichen Planus
Detailed Description:
Background Oral lichen planus OLP is a chronic inflammatory disorder affecting the mucous membranes believed to be an immune-mediated condition Its persisting nature can lead to extended discomfort for those affected The primary symptoms are pain and a burning sensation with a potential risk of malignancy if not properly managed necessitating lifelong clinical monitoring Presently OLP is considered a significant challenge due to the absence of a definitive cure
Patients patients Thirty patients with oral lichen planus were divided into three groups 10 patients each Group A ten patients with OLP were received topical triamcinolone acetonide Group B ten patients with OLP were received topical curcumin Group C ten patients with oral lichen planus were received topical triamcinolone acetonide combiend with topical curcumin For six weeks Each patient was examined at baseline1 and 3months of therapy Pain was scored using the visual analogue scale Salivary level of interleukin 1 were estimated at baseline1and 3 months evaluation periods
Patients patients Thirty patients with oral lichen planus were divided into three groups 10 patients each Group A ten patients with OLP were received topical triamcinolone acetonide Group B ten patients with OLP were received topical curcumin Group C ten patients with oral lichen planus were received topical triamcinolone acetonide combiend with topical curcumin For six weeks Each patient was examined at baseline1 and 3months of therapy Pain was scored using the visual analogue scale Salivary level of interleukin 1 were estimated at baseline1and 3 months evaluation periods
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None